ZMYM2 and schizophrenia: ZMYM2 was supported by substantial evidence from the literature45–47 including suggestive meta-analysis results from exome studies of schizophrenia (SCHEMA p-value = 1.79 × 10−5)40, and no rare LoF variants detected in our TOF-control sample (Table 3, Supplementary Fig. S4).